Meraf Wolle is an Ophthalmology physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1221 Mercantile Ln
Upper Marlboro, MD 207745374
Telephone
301-618-5578Provider last certified this registry record 20 Oct 2023.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Sun Pharmaceutical Industries Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
57%Corticosteroid22.1%Prednisolone Acetate93%Fluorometholone7%Part D≥191 patientsProstaglandin Analog17.1%Latanoprost100%Part D≥148 patients+ 6 more classes in this area
Anti-infectives
19.4%Fluoroquinolone Antibacterial12.3%Moxifloxacin100%Part D≥140 patientsMacrolide4.6%Erythromycin100%Part D≥29 patients+ 1 more class in this area
Musculoskeletal
10.5%Cyclooxygenase Inhibitor9.4%Ketorolac Tromethamine100%Part D≥78 patientsNonsteroidal Anti-inflammatory Drug1.1%Diclofenac Sodium100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2020–2022 per NIH RePORTER. The latest:
- Trachomatous Trichiasis and Predicting the End of Blinding Trachoma
Johns Hopkins University
FY2022$214,707K23EY030162 - Trachomatous Trichiasis and Predicting the End of Blinding Trachoma
Johns Hopkins University
FY2021$209,655K23EY030162 - Trachomatous Trichiasis and Predicting the End of Blinding Trachoma
Johns Hopkins University
FY2020$214,023K23EY030162
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”